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The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients
have supported the idea that lifestyle factors may protect against the clinical
manifestations of AD rather than influence AD neuropathological processes (the
cognitive reserve hypothesis). This evidence argues in favor of the hypothesis that
lifestyle factors act as moderators between AD pathology and cognition, i.e., through
indirect compensatory mechanisms. In this review, we identify emerging evidence
in cognitively normal older adults that relate lifestyle factors to established AD
neuroimaging biomarkers. While some of these investigations are in agreement with
the compensatory view of cognitive reserve, other studies have revealed new clues
on the neural mechanisms underlying beneficial effects of lifestyle factors on the
brain. Specifically, they provide novel evidence suggesting direct effects of lifestyle
factors on AD neuropathological processes. We propose a tentative theoretical
model where lifestyle factors may act via direct neuroprotective and/or indirect
compensatory mechanisms. Importantly, we suggest that neuroprotective mechanisms
may have a major role during early stages and compensatory mechanisms in
later stages of the disease. In the absence of an effective treatment for AD and
considering the potential of lifestyle factors in AD prevention, understanding the neural
mechanisms underlying lifestyle effects on the brain seems crucial. We hope to
provide an integrative view that may help to better understand the complex effects
of lifestyle factors on AD neuropathological processes, starting from the preclinical
stage.
Keywords: cognitive reserve, brain reserve, neuroimaging, Alzheimer’s disease, amyloid, preclinical Alzheimer’s
disease, compensation, neuroprotection
Introduction
In the absence of effective treatments for Alzheimer’s disease (AD), new therapeutical approaches
that may assist in preventing and/or delaying the onset of AD appear essential. Lifestyle factors such
as cognitive, social and/or physical activities have a great potential for AD prevention (Barnes and
Yaffe, 2011; Erickson et al., 2012). Therefore, understanding the biological mechanisms underlying
lifestyle effects on the brain seems crucial.
During the last decades, several theories have provided a conceptual framework to study the
effects of lifestyle factors on the brain. In the present review, we are interested in cognitive and
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brain reserve theories (Stern, 2002; Satz et al., 2011), with
special interest in cognitive reserve. Cognitive reserve is a pivotal
concept that has driven several neuroimaging investigations, and
has found support in the vast majority of these investigations in
AD. More recently, notably due to the development of β-amyloid
(Aβ) ligands and the definition of preclinical AD (Sperling
et al., 2011), new evidence has arisen from studies in cognitively
normal older adults. These studies relate lifestyle factors to
AD neuropathological processes by means of AD neuroimaging
biomarkers (i.e., Aβ deposition, atrophy and hypometabolism).
While cognitive reserve argues in favor of lifestyle factors as
moderators between AD pathology and cognition, implying that
lifestyle effect would be independent of AD pathology (Stern,
2002), we will identify emerging neuroimaging evidence in
cognitively normal older adults showing a direct effect of lifestyle
factors on AD neuropathological processes.
The review is organized as follows. First, we provide a brief
overview of cognitive and brain reserve theories. Then, we
focus on evidence that relate AD neuroimaging biomarkers
(i.e., Aβ deposition, hypometabolism and atrophy) to lifestyle
factors, first in AD patients and then in cognitively normal older
adults. Evidence focused on the relationship between lifestyle
factors and cognitive performances will not be included in the
present review. Moreover, although cognitive and brain reserve
theories have also been investigated in other neurodegenerative
diseases, such as frontotemporal dementia, Parkinson disease
and Huntington’s disease (Borroni et al., 2012), this review
only elaborates on the concept of reserve in the framework of
neuroimaging research in AD. In the last section of the review,
we discuss the potential mechanisms underlying the effects
of lifestyle factors, i.e., neuroprotection and compensation,
also taking into account evidence from other fields such as
research in animals and intervention studies. We emphasize
recent investigations in preclinical AD that have provided
new insights into the field. Overall, we hope to provide an
integrative view that may represent a first step towards a
broader theoretical model that considers both indirect and
direct effects of lifestyle factors on AD neuropathological
processes, extending from cognitively normal older adults to AD
patients.
Brief Definition of Cognitive and Brain
Reserve and Current Approach
In the field of aging and dementia, the concept of ‘‘reserve’’
stems from the repeated observation that there is a discrepancy
between the degree of neuropathological changes associated
with aging and AD and their clinical expression (for example,
Katzman et al., 1989). Thus, ‘‘reserve’’ refers to the hypothetical
capacity of the brain to tolerate more aging or pathological
effects, thereby reducing the impact on clinical symptoms (Stern,
2002).
There have been different attempts to conceptualize ‘‘reserve’’
including passive (Katzman, 1993; Satz et al., 1993; Mortimer,
1997) and active models. The passive model revolves around
brain reserve concept and refers to quantitative characteristics
that may help to tolerate adverse effects of neuropathology, such
as brain size (Katzman, 1993) or neuronal count (Mortimer et al.,
1981). According to the passive model, there is a threshold at
which clinical deficits will become apparent and those subjects
with more brain reserve (e.g., bigger brains) require more
pathology to reach that threshold (Satz et al., 1993). The active
model revolves around cognitive reserve concept and refers
to how flexibly and efficiently an individual can make use of
available brain reserve (Stern, 2002). Cognitive reserve implies
variability at the level of brain networks (Stern, 2009), i.e.,
interindividual differences in the ability to use brain networks
in an effective way. This includes preexisting differences
in neural preprocessing (neural reserve), and alterations in
neural processing that may take place in order to cope
with increasing brain pathology (neural compensation; Stern,
2009). Thus, while brain reserve emphasizes the anatomical
potential or brain structure, cognitive reserve emphasizes brain
function.
It needs to be noted that reserve is a hypothetical construct
and thus, direct measures of reserve are not available (Jones
et al., 2011). Therefore, surrogate or proxy measures are used
to approach reserve. Proposed surrogate or proxy measures of
brain reserve include measures of neuronal number, dendritic
arborization or synapse density (Stern, 2002). Measures such
as brain volumes (Solé-Padullés et al., 2009) intracranial
volume (ICV, as a proxy for maximal brain volume) or
head circumference (for example, Mortimer et al., 2005) have
also been used in the literature. In addition, based on solid
epidemiological evidence (see for example, Meng and D’Arcy,
2012), education (Stern et al., 1992) and IQ (Alexander et al.,
1997) are also considered as standard proxies of cognitive
reserve. This has been extended to include other proxies
such as occupation (Stern et al., 1994; Richards and Sacker,
2003; Staff et al., 2004), engagement in leisure and cognitive
activities (Scarmeas et al., 2001, 2003a; Wilson et al., 2002),
social networks (Fratiglioni et al., 2000; Bennett et al., 2006),
dietary habits (Scarmeas et al., 2006) and more generally a
mental stimulating lifestyle clustered around the concept of
cognitive lifestyle (Valenzuela and Sachdev, 2006). Performance-
based measures (such as vocabulary or reading tests) have
also been used as they are thought to show little change
with age and remain relatively preserved in the early stages
of dementia (for example, Park et al., 2002; Wisdom et al.,
2012). Finally, factors reflecting the variance between two or
more of these variables (Scarmeas et al., 2004; Bartrés-Faz
et al., 2009; Solé-Padullés et al., 2009; Bosch et al., 2010)
have also been used. The present review considers proxies
or surrogates of reserve as reflecting lifestyle involvement in
cognitive (including educational attainment and occupation),
physical and social activities. These proxies will be referred
to as lifestyle factors or positive lifestyle factors throughout
the manuscript to avoid confusion. We recognize the effect of
these variables not only in relation to the concept of cognitive
reserve, but also above this concept. Indeed we acknowledge the
possibility that these factors may impact on the manifestation
of AD not only through cognitive reserve mechanisms but also
by exerting their impact on the neuropathological processes
of AD. Finally, although epidemiological data suggested other
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modulating factors that may alter the clinical expression of
the disease (i.e., vascular risk factors such as hypertension,
hypercholesterolemia and diabetes) they were not within the
scope of the present review.
The present review is based on the assumption that cognitive
and brain reserve theories may provide independent as well
as interactive contributions, because of different reasons. First,
functional differences in cognitive processing (cognitive reserve)
might be sustained by an anatomical substrate (brain reserve;
Stern, 2009). Furthermore, brain reserve proxies (which are a
static measure from a strict theoretical point of view) might
be modifiable through lifestyle variables, as shown for example
with brain volumes in neuroimaging and interventional studies
(see for example, Erickson et al., 2011). Thus, lifestyle variables
may influence both brain structure (brain reserve) and function
(cognitive reserve; Bartrés-Faz et al., 2009; Arenaza-Urquijo
et al., 2013a). Finally, evidence from studies considering a
life course approach to the effects of lifestyle suggests that
a genetically endowed advantage may lead, for example, to
larger brains (brain reserve) and may then influence individual’s
choices such as education, occupation, intellectual and physical
activities (Staff et al., 2012), which may in turn impact cognitive
reserve. Thus, the differentiation between cognitive and brain
reserve seems to be strictly theoretical and somehow artificial.
However, different methodological approaches have been used
to study these two concepts. In the present review, we assume
that lifestyle factors may influence both brain structure and
function. Studies that do not assess the relationship between
lifestyle factors and brain measures but the characteristics
that differentiate a control group from a case group (for
example, cognitively normal Aβ positive as compared to Aβ
negative subjects) would be considered under the brain reserve
model.
Cognitive Reserve, Lifestyle and
Alzheimer’s Disease Neuroimaging
Markers: from Alzheimer’s Disease
Dementia to Preclinical Stages
Summary of Previous Findings in Alzheimer’s
Disease Patients
In AD patients cognitive reserve theory predicts that the
clinical manifestation of advancing AD pathology would be
delayed in patients with higher exposure to cognitive, social
and physical activities. This implies first, that neuropathological
effects of AD would need to be more severe for the
clinical symptoms of dementia to become evident and second,
that more resources might be available in these individuals
which may allow them to maintain cognitive function (see
Figure 1).
A common approach in neuroimaging investigations consists
in assessing the relationships between: (i) lifestyle factor(s); (ii)
a marker of AD pathology (such as hypometabolism, atrophy
or Aβ deposition); and (iii) cognition/clinical severity. Very
often, this approach turned into a model where the relationships
between lifestyle variables and neuroimaging measures have
FIGURE 1 | Theoretical illustration of how cognitive reserve may
mediate the relationships between AD neuropathology and cognitive
function (adapted from Stern, 2009).
been assessed controlling for clinical severity. Consequently,
given comparable clinical severity, positive lifestyle variables
are expected to correlate with greater AD pathological changes
pathology, thus indicating a higher tolerance. This first approach
has provided strong evidence that neuroimaging biomarkers
are more affected at a given level of cognitive performance
in patients with higher exposure to positive lifestyle factors,
when compared to patients with lower exposure to these
factors. This has been shown for neuroimaging markers of
perfusion in mild to moderate AD patients (Stern et al.,
1992, 1994; Liao et al., 2005), glucose metabolism in AD
(Alexander et al., 1997; Kemppainen et al., 2008) and mild
cognitive impairment (MCI) converters (Garibotto et al., 2008),
atrophy in MCI and AD (Kidron et al., 1997; Querbes et al.,
2009; Solé-Padullés et al., 2009; Seo et al., 2011) and Aβ
deposition in AD patients (Kemppainen et al., 2008). When
the topography of the relationships has been investigated
(for example using voxel-wise approaches), studies generally
point to brain areas known to be vulnerable in AD, such
as temporal and parietal areas (including medial areas such
as the hippocampus and the precuneus) and the ventrolateral
frontal cortex (for Aβ deposition). However, metabolism/
perfusion changes in other brain areas (not specifically sensitive
to AD) have also been highlighted in previous studies,
such as frontal (Stern et al., 1994; Alexander et al., 1997;
Scarmeas et al., 2003b) or occipital (Scarmeas et al., 2003b)
regions.
Another frequently used approach consists in assessing the
relationships between neuroimaging markers and cognitive
performances and then identifying the interactions between
lifestyle factors and AD neuropathology on cognition. In other
words, these investigations study whether lifestyle variables
modulate the relationship between AD pathology and cognitive
function. Roe et al. (2007) for example showed that Aβ
deposition (measured using PIB uptake) interacted with years
of education in predicting cognitive function. Performance
on cognitive measures increased with increasing education
for participants with elevated Aβ deposition but education
was not related to global cognitive functioning scores among
participants with low Aβ deposition. This suggests that
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individuals with more years of education were able to
maintain cognitive function in the presence of cortical Aβ.
Independent effects of lifestyle factors and AD pathology
on cognition have been found in subsequent studies by
Vemuri et al. (2012) in a pooled group of MCI and AD
patients and using both structural abnormalities in AD regions
and cerebrospinal (CSF) Aβ1–42 levels (see also ‘‘Preclinical
Alzheimer’s Disease: Lifestyle Effects on AD Neuroimaging
Biomarkers’’ Section) and a cognitive score compelling several
domains (language, memory, executive, and visual); and by
Rentz et al. (2010) in a pooled sample of healthy older adults
and AD patients using Aβ deposition measured with PIB-PET
and including a wide range of cognitive domains as well as
a challenging memory test (see also ‘‘Preclinical Alzheimer’s
Disease: Lifestyle Effects on AD Neuroimaging Biomarkers’’
Section).
Overall, studies in AD patients (some of them also including
MCI patients) showed greater AD pathology in patients with
higher exposure to positive lifestyle factors compared to patients
with lower exposure (at the same cognitive level), consistent with
the idea that reserve increases the tolerace to AD pathology.
However, it needs to be noted that the reverse findings
(more preserved brains in AD patients with higher exposure
to positive lifestyle factors) have also been reported in some
studies (Lo et al., 2013; Shpanskaya et al., 2014) as discussed
below.
Preclinical Alzheimer’s Disease: Lifestyle Effects
on AD Neuroimaging Biomarkers
In the last years, notably with the emergence of Aβ imaging
and the establishment of preclinical AD criteria (Sperling et al.,
FIGURE 2 | Illustration of the interactions between Aβ status
(positive vs. negative) and cognitive reserve proxies on
hippocampal volume reprinted from Arenaza-Urquijo et al.
(2013b; with permission from IOS Press). The scatterplot shows
an inverse relationships between cognitive reserve markers and AD
neuroimaging biomarkers restricted to cognitively normal Aβ positive
subjects (in red).
2011), new findings have emerged in cognitively normal older
individuals. These studies included: (i) samples of cognitively
normal older adults with neuroimaging biomarker information
(and CSF markers in some of them); or (ii) older adults
considered to be at higher risk for AD (that may thus in part
represent the preclinical AD stage), such as older adults showing
pathological levels of Aβ deposition or carrying the ε4 allele of
the Apolipoprotein (APOE) gene (the highest known genetic risk
factor for sporadic AD).
While some of these investigations are in agreement with the
notion that lifestyle factors may have a modulatory effect on the
brain, other studies provide new clues on the neural mechanisms
underlying the effects of lifestyle factors on the brain and thus
on the potential mechanisms underlying cognitive and brain
reserve. These studies: (i) propose that certain anatomical or
functional characteristics (for example, greater temporal volume
or metabolism) may delay the deleterious effect of Aβ; and
interestingly; (ii) provide novel evidence showing a direct effect
of lifestyle variables on AD neuropathological processes, for
example, by slowing Aβ deposition.
Lifestyle Effects in Cognitively Normal Individuals at
Higher Risk for AD
A first series of studies investigated the relationships between
lifestyle and neuroimaging markers controlling for cognitive
performance (see above for justification), in samples of
cognitively normal Aβ positive subjects classified by means
of CSF Aβ1–42 levels. In a sample from the prospective
Alzheimer’s Disease Neuroimaging Initiative (ADNI) study,
Ewers et al. (2013) found that higher education was associated
with lower FDG-PET glucose metabolism in Aβ positive, but
not in Aβ negative subjects. In the same vein, Arenaza-
Urquijo et al. (2013b), using a comprehensive proxy of
cognitive reserve, reported that relatively to Aβ negative,
Aβ positive subjects with higher scores on this variable
presented greater atrophy in the hippocampus and cortical
thinning in the supramarginal gyrus. In agreement with
previous evidence in AD, authors claimed that in asymptomatic
individuals with abnormal levels of Aβ (which may reflect
the preclinical stage of AD) higher exposure to positive
lifestyle variables compensates FDG-PET hypometabolism or
gray matter atrophy/cortical thinning to maintain cognitive
performance (see Figure 2). Using a different approach, Rentz
et al. (2010) were able to show that a cognitive reserve factor
(education and reading test) could moderate the relationships
between Aβ deposition and cognitive performances in a
sample including cognitively normal and mild AD patients
(see also "Preclinical Alzheimer’s Disease: Lifestyle Effects on
AD Neuroimaging Biomarkers’’ Section). In the subsample
of cognitively normal older adults, they showed that Aβ
deposition in the precuneus was associated with reduced
memory performance and this relationship was weaker in
subjects with higher cognitive reserve proxies, suggesting that
cognitive reserve may be protective against Aβ-related cognitive
impairment.
The studies by Chételat et al. (2010) and Johnson et al.
(2014) provide complementary information. Rather than
Frontiers in Aging Neuroscience | www.frontiersin.org 4 August 2015 | Volume 7 | Article 134
Arenaza-Urquijo et al. Lifestyle effects on AD neuroimaging biomarkers
studying the relationships between lifestyle variables and
brain measures, these studies highlighted the differences
between cognitively normal older adults with high (Aβ-
positive) vs. low (Aβ-negative) Aβ deposition. Chételat
et al. (2010) showed that asymptomatic Aβ-positive had
larger temporal (including hippocampal) gray matter volume
than Aβ-negative individuals, which was associated with
better episodic memory performance. In the same vein,
Johnson et al. (2014) reported increased metabolism in
the superior temporal lobe, and increased gray matter in
the lateral parietal lobe, in Aβ-positive compared to Aβ-
negative subjects. In accordance with the brain reserve
hypothesis, we could suggest that the deleterious effects of
Aβ deposition on cognition might be delayed in individuals
with higher gray matter volumes or higher glucose metabolism.
Although these mechanisms may be somehow passive, neural
compensation related to more detailed memory encoding
in older adults with Aβ deposition has also been reported
(Elman et al., 2014). Thus, cognitively normal older adults
with Aβ deposition may recruit extra neural resources,
including increases in brain activation in the parietal and
occipital cortex that may allow them to maintain normal
cognition.
Altogether, some of these studies showed greater tolerance
to neurodegeneration (atrophy and hypometabolism) in
asymptomatic (Aβ-positive) older adults with higher exposure
to positive lifestyle factors, which is in line with evidence in AD
patients. Other studies, point to brain reserve mechanisms
that may help delaying the effects of Aβ deposition on
cognition. Studies that directly assess the link between AD
neuropathological processes, potential reserve mechanisms and
lifestyle are not available yet.
Lifestyle Effects on AD Neuroimaging Biomarkers in
Cognitively Normal Subjects and APOE ε4 Carriers
Liang et al. (2010) provided novel associations between
exercise engagement and biomarkers levels (measured with
PET-PIB and CSF levels of Aβ1–42, tau and phospho-tau).
They observed that subjects with greater physical activity
had lower Aβ deposition. In fact, when they compared
exercise scores between individuals with ‘‘at risk’’ biomarkers
levels and individuals with ‘‘normal’’ levels those with more
altered biomarkers were more sedentary. A later study by
Landau et al. (2012) further supported the idea that lifestyle
factors may have a direct effect on brain Aβ pathology.
They showed an inverse association between Aβ deposition
(measured using PIB) and lifelong cognitive activities in
cognitively normal subjects. In line with the report in physical
activities, healthy older participants in the lowest cognitive
activity tertile had Aβ levels similar to patients with AD.
This finding was confirmed in a subsequent study from
the same laboratory using path analyses and an increased
sample size (Wirth et al., 2014a). Further, a series of
recent investigations from different laboratories suggest that
effects of cognitive and physical activities on Aβ deposition
might be exacerbated in those individuals with an APOE ε4
allele (Head et al., 2012; Brown et al., 2013; Wirth et al.,
2014b; see Figure 3). Finally, a recent study (Okonkwo
et al., 2014) in late middle-age cognitively normal individuals
showed that age-related alteration in Aβ deposition, glucose
metabolism of the precuneus and hippocampal volume was
attenuated in subjects with higher involvement in physical
activity.
Similar direct effects on hippocampal atrophy were shown
in a longitudinal study by Valenzuela et al. (2008) where
complex mental activity across the lifespan was related
to reduced hippocampal atrophy in cognitively normal
older people. In line with this observation, occupational
complexity, specifically supervisory experience at work, has
also been related to a lower rate of hippocampal atrophy
in cognitively normal older adults (Suo et al., 2012), and
higher educational attainment was reported to be related
to decreased hippocampal perfusion (Piras et al., 2011).
Beyond the hippocampus, an effect of education, occupation
and leisure activities on temporal and parietal gray matter
volumes and cortical thinning has also been reported
(Foubert-Samier et al., 2012; Liu et al., 2012; Arenaza-
Urquijo et al., 2013a). However, two studies including a
large sample of cognitively normal individuals from ADNI
found inconsistent results. A cross-sectional study did not
replicate these positive effects of lifestyle factors on AD
neuropathological processes (Vemuri et al., 2012). Thus,
no significant correlation was found between lifetime or
current intellectual activity and Aβ PET, glucose metabolism
or hippocampal volumes (however, all these biomarkers
were associated with cognitive performance). A subsequent
longitudinal study using ADNI subjects (Lo et al., 2013),
investigated the effects of cognitive reserve (i.e., education,
IQ and occupation) and brain reserve (i.e., intracranial size)
proxies on AD pathological progression, including CSF Aβ1–42,
FDG-PET and hippocampal volumes. Only CSF Aβ1–42 was
found to be influenced by cognitive reserve proxies in cognitively
normal elders.
In summary, emerging evidence suggest that lifestyle factors
such as cognitive and physical activity may also have direct effects
on Aβ deposition and rates of Aβ accumulation. These direct
effects might be restricted to cognitively normal older adults,
and may be exacerbated in APOE ε4 carriers. Finally, direct
effects of lifestyle in key regions such as the hippocampus and the
temporal lobe have also found support in several cross-sectional
studies.
Discussion
Currently, the relationships between lifestyle, AD
neuropathology and cognition remain unclear despite the
relevance of this question for our understanding ofhealthy
aging, and the potential impact for intervention and
prevention. From a theoretical perspective, we propose
to integrate new evidence in preclinical AD to previous
studies in AD in a general model (Figure 4). This model
does not aim to capture the full complexity of lifestyle
effects on the brain, but attempts to frame our current
understanding of the relationships between lifestyle and AD
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FIGURE 3 | (A) Association between past cognitive activity score and
cortical PIB-uptake, reprinted from Landau et al. (2012; with permission)
and interaction between cognitive activity and APOE ε4 on global PIB
retention reprinted from Wirth et al. (2014b; with permission). (B)
Association between physical activity and PIB mean cortical binding
potential reprinted from Liang et al. (2010; with permission) and
interaction between physical activity and APOE ε4 on mean cortical
binding potential, reprinted from Head et al. (2012; with permission).
neuropathology over the course of the disease. Neuroimaging
studies in AD and cognitively normal elders (including
preclinical AD) will be the guiding threat for discussion,
while complementary evidence from other fields will be
used as supports to discuss on the potential underlying
mechanisms.
Potential Mechanisms Underlying Lifestyle
Effects
Lifestyle factors were initially suggested as moderators
between brain changes and cognitive performance, under
the cognitive reserve hypothesis (Stern, 2002), as represented
in Figure 4A. This implies that lifestyle factors may protect
against the clinical manifestations of AD rather than
influence AD neuropathological processes. Nowadays,
growing neuroimaging evidence in cognitively normal
individuals points to potential links between lifestyle factors
and AD neuropathological expression (Figure 4B), which
suggests that the effects of lifestyle might be exerted via
both compensatory and neuroprotective mechanisms. In the
present review we argue that lifestyle-related compensatory
and neuroprotective mechanisms may coexist and play a
differential (but not exclusive) role along the disease with
neuroprotective mechanisms having a major role in early stages
and compensatory mechanisms later in the disease progression
(Figure 4C).
Compensatory Mechanisms
The abovementioned studies in AD patients, showing more
altered biomarkers (hypometabolism, atrophy and Aβ) in
patients with higher exposure to positive lifestyle factors, argue
in favor of compensatorymechanisms underlying lifestyle effects.
According to this view, more pathology is necessary for clinical
symptoms to become apparent (Stern, 2009). While, this implies
that lifestyle may help delaying or masking cognitive decline, it
also implies that once clinical symptoms appear the pathology
would be more advanced. This idea is supported by several
studies showing that older individuals with higher years of
education and/or occupation (Teri et al., 1995; Rasmusson
et al., 1996; Unverzagt et al., 1998; Stern et al., 1999; Wilson
et al., 2004; Amieva et al., 2005; Hall et al., 2007) and
participation in cognitive or leisure activities (Helzner et al.,
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FIGURE 4 | Theoretical illustrations of the potential effects of lifestyle
factors. (A) Lifestyle factors may act as moderators between brain pathology
and cognition, as posited by the cognitive reserve model. (B) Lifestyle factors
may have a direct (neuroprotective) effect on AD neuropathology, as shown by
more recent neuroimaging studies. (C) Lifestyle factors may act through both
neuroprotective and compensatory pathways, that may coexist. Lifesytle
factors may have a direct effect on AD pathological processes in cognitively
normal older adults. However, when the pathology reaches a certain level,
lifestyle factors may only moderate the relation between AD pathology and
cognition. In other words, neuroprotective processess may have a major role
in early stages, and compensatory processess later in the disease
progression.
2007; Hall et al., 2009) had delayed memory decline but a
more rapid decline after disease onset. Moreover, this notion
is also supported by autopsy studies showing a modifier effect
of lifestyle factors in the relation of Aβ pathology to cognition
(Del Ser et al., 1999; Bennett et al., 2003; Mortimer et al.,
2005) rather than a direct relation between lifestyle factors and
development of AD pathology (for a review, see Bennett et al.,
2014).
Another important implication of these findings is that
lifestyle factors may exert their effect through compensatory
mechanisms such as neural compensation. Compensatory
mechanisms related to healthy aging and AD have been often
reported, and maybe strengthened by lifestyle factors (Park
and Reuter-Lorenz, 2009). In fact, neural compensation related
to cognitive reserve proxies (i.e., education, IQ and/or leisure
activities) has been described in AD and/or MCI patients
as compared to older controls using different fMRI task,
such as non-verbal memory (Scarmeas et al., 2004), encoding
memory (Solé-Padullés et al., 2009) and language (Bosch et al.,
2010). Neural compensation for the effects of Aβ and/or
hippocampal atrophy on memory have been described in Aβ
positive cognitively normal elders (Elman et al., 2014) and
MCI patients (Huijbers et al., 2015), however, it is still unclear
for which aspects of AD neuropathology patients are able to
compensate.
Despite this general agreement for a compensatory
perspective in AD, potential direct effects of lifestyle factors
(education and/IQ) on AD pathology have also been described
in AD patients (Lo et al., 2013; Shpanskaya et al., 2014). Thus,
as represented in Figure 4B, an alternative possibility is that
lifestyle factors directly impact on AD neuropathological
processes.
Neuroprotective Mechanisms
Exposure to positive lifestyle factors may protect against
the development of the disease for example, by slowing Aβ
deposition or rates of hippocampal atrophy (Valenzuela et al.,
2008; Liang et al., 2010; Landau et al., 2012). In contrast
to previous evidence arguing for compensatory processes
in AD patients, evidence for a direct relationship between
lifestyle factors and AD neuropathological processes have
mainly been reported in cognitively normal older adults.
Although only poorly supported by autopsy studies (for a
review, see Bennett et al., 2014), this idea has received
further support from animal and intervention studies. Thus,
researches in animals showed, for example, increased clearance
of Aβ and reduced Aβ levels in mice exposed to enriching
environments (Lazarov et al., 2005; Costa et al., 2007).
Intervention studies on the other hand reported increases in
hippocampal size (Erickson et al., 2011) and perfusion (Burdette
et al., 2010) with exercise training and biochemical changes
in the hippocampus after cognitive training (Valenzuela et al.,
2003).
Although this review focuses on brain regions known
to be vulnerable to AD, it needs to be noted that these
direct/neuroprotective effects of lifestyle factors may extend to
other brain areas. In fact, neuroimaging studies in cognitively
healthy older adults have shown that lifestyle effects may
extend to the frontal lobe, where changes in gray matter and
glucose metabolism in cognitively normal elders have been
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evidenced (Foubert-Samier et al., 2012; Arenaza-Urquijo et al.,
2013a). It remains unclear however, whether these changes help
maintaining cognitive functioning later in the disease evolution
(for example when Aβ deposition becomes elevated). Increase
in volume or metabolism in brain areas not sensitive to AD
may indeed help coping with the progressing AD pathology
(i.e., Aβ deposition and decreased volume and metabolism
in AD-sensitive brain areas), which would result in delayed
cognitive decline. For example, higher temporal or parietal
gray matter volume (Chételat et al., 2010; Johnson et al.,
2014) or higher basal metabolism may help coping with the
effects of Aβ on cognition (Cohen et al., 2009; Johnson et al.,
2014). This more ‘‘passive’’ compensatory mechanism might
co-occur with more active mechanisms such as the neural
compensation described above. Whether these increases in
volume and metabolism are provided by lifestyle experiences
or may be related to brain reserve (innate differences) or
both, i.e., initial advantages may be promoted by lifestyle,
remains unclear and needs to be clarified in longitudinal
studies.
Compensatory and Neuroprotective Mechanisms
Over the Course of Alzheimer’s Disease
It is unlikely that lifestyle factors act exclusively through
neuroprotective or through compensatory mechanisms. Indeed,
these two mechanisms may coexist. As illustrated in Figure 4C,
lifestyle variables may play a double role in preventing AD
neuropathology and attenuating the impact of this pathology
on cognition via compensatory mechanisms. In fact, despite
strong evidence toward compensatory mechanisms in AD
patients, there is some neuroimaging evidence for direct
protective effects of lifestyle factors in AD, reporting for
e.g., slower rates of metabolism decline in high educated
AD patients (Lo et al., 2013). Since almost all previous
evidence in AD is cross-sectional, it is possible that direct
effects on AD neuropathological progression were masked
by baseline differences; longitudinal studies might thus allow
detecting such direct effects of lifestyle factors on AD
pathology.
In the absence of longitudinal studies, cross-sectional studies
across different clinical groups (for example healthy older adults,
MCI and AD) may offer some important information as regard
the differential role that lifestyle factors may play over the
course of the disease. For example, differential relationships
between lifestyle factors in cognitively normal elders, MCI and
AD patients have been reported (Lo et al., 2013), including
with measures of cortical thickness (Liu et al., 2012) and whole
brain volumes (Solé-Padullés et al., 2009). These studies point
to direct effects of lifestyle variables in cognitively normal
elders (i.e., increased brain volume, cortical thickness or slower
rate of amyloid deposition) and indirect effects (e.g., decreased
brain volume or cortical thickness) in patients. These findings
converge with those of fMRI studies showing differential
patterns of activations in normal older adults vs. patients. Thus,
comparing individuals with high vs. low exposure to positive
lifestyle variables, lower task-related activation in cognitively
normal older adults vs. higher activation in patients have been
described. These results might reflect increased neural efficiency
in cognitively normal older adults (i.e., less resources are needed
to perform a task) vs. neural compensation (i.e., more resources
are needed to perform the task) in patients (for a review, see
Bartrés-Faz and Arenaza-Urquijo, 2011).
A complementary idea is that increasing Aβ deposition may
represent a turning point where lifestyle-related compensatory
mechanisms would start taking place. Although compensation
for other aspects of aging might exit, within the context of AD
this idea looks plausible. Aβ deposition is considered a pivotal
event in the AD pathologic cascade that may exacerbate changes
in glucose metabolism and atrophy. It is possible that direct
effects of lifestyle factors on Aβ deposition only occurs before
cognitive impairment. Indeed, this converge with the fact that
effects of lifestyle factors on Aβ deposition have been restricted
to cognitively normal elders (see above). Thereby, we propose
that lifestyle factors may exert their effects mainly through
neuroprotective mechanisms in early stages (as evidenced in
cognitively normal subjects) and compensatory mechanisms
later in the disease progression (as shown in AD patients),
as illustrated in Figure 4C. In a simplified scenario where we
consider that Aβ-positive subjects are in the pathway toward AD,
reports showing that cognitively normal Aβ-positive subjects
with higher cognitive reserve proxies had greater atrophy and
glucose hypometabolism in AD vulnerable regions (Arenaza-
Urquijo et al., 2013b; Ewers et al., 2013) might be interpreted as
evidence for a greater tolerance to pathology in these subjects,
which allows them to remain cognitively normal while they are
more advanced in the pathway to AD. Conversely, cognitively
normal Aβ-positive subjects with lower exposure to positive
lifestyle variables may have progressed to MCI at this stage of
brain alteration (atrophy and hypometabolism). This differential
relationship between lifestyle factors and metabolism or gray
matter volume in Aβ-positive and Aβ-negative cognitively
normal older adults, suggests that the inclusion of older adults at
higher risk of developing dementia (for example, presenting high
Aβ deposition; Bartrés-Faz and Arenaza-Urquijo, 2011; Arenaza-
Urquijo et al., 2013a) or subjects in pre-and post-amyloid plaque
stages (Jagust and Mormino, 2011) might be a major confound
that needs to be considered in future studies. Furthermore,
this might explain some results in previous studies in healthy
older adults where this variable was not taken into account,
showing associations similar to those found in AD (i.e., negative
correlations between positive lifestyle factors and measures of
brain integrity) in cognitively normal adults (Coffey et al., 1999;
Querbes et al., 2009; Bastin et al., 2012).
It is important to point out that other concepts than
cognitive reserve, such as brain maintenance (Nyberg et al.,
2012), that emphasize neuroprotective mechanisms related
to a higher resistance to pathological processes, may be
considered to explain direct effects on AD neuropathological
processes. Indeed, a previous review by Barulli and Stern
(2013) proposed that cognitive reserve, brain reserve and brain
maintenance models may be complementary to explain different
aspects of resilience to pathology, including both aspects
related to maintaining brain integrity (brain maintenance,
Nyberg et al., 2012), and potential compensatory mechanisms
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(cognitive reserve). In line with this, several authors have
discussed this new evidence including the notion that
lifestyle variables may have an impact on AD neuropathology
(see for example, Vemuri and Mormino, 2013). Here, we
emphasize the need to consider the disease progression to
improve our understanding of the effects of lifestyle on AD
neuropathology.
Summary and Perspectives
Complementary evidence from AD and preclinical AD
researches point to the idea that lifestyle factors such as cognitive,
physical and social activities may exert their effects through
both neuroprotective and compensatory mechanisms. While
studies in AD patients point to lifestyle-related compensatory
mechanisms, new evidence in cognitively normal elders with AD
neuroimaging biomarkers and preclinical AD subjects suggests
that lifestyle factors may directly impact the development
of AD neuropathology. In the present review, we propose
that including a perspective on disease progression may
thus allow a better understanding of lifestyle effects on AD
neuropathological processes. Neuroprotective mechanisms
may be at work mainly early in the disease progression while
compensatory mechanisms may predominate in later stages of
the disease. Thus, lifestyle-related neuroprotective mechanisms
may no longer be efficient once the pathological processes
have progressed. Future research focusing in the relation
between lifestyle factors, AD neuropathology, and potential
compensatory mechanisms probably using task-related fMRI
approaches are needed to confirm this view. Furthermore, studies
assessing both lifestyle-related neuroprotective mechanisms
and compensatory processes across different clinical and
pathological stages of the disease will shed light into this
issue.
It needs to be acknowledged that results showing an
impact of lifestyle factors on AD neuropathology (for example,
on Aβ deposition) in cognitively normal elders are novel
and more evidence still needs to accumulate. These results
however appear reliable as converging evidence comes from
different laboratories (i.e., different samples), and using different
lifestyle variables (for example, cognitive activities or physical
activities).
As also pointed throughout this review, our understanding
of lifestyle effects might be hampered by different issues
that need to be considered in future research. First, because
of the cross-sectional design of the majority of studies, the
effects of lifestyle factors on the rate of decline of AD
biomarkers have not been fully assessed. Thus, longitudinal
studies are needed to evaluate this question considering
potential baseline differences in biomarker alteration. Second,
the definition of a valid and accurate quantitative neural
measure of cognitive reserve is very challenging. In this regard,
functional connectivity measures (reflecting the synchronization
of neuronal activity between anatomically separate brain
regions, Biswal et al., 1995), may provide new insights into
the field. Indeed, functional connectivity might be shaped
by experience such as cognitive training (e.g., Jolles et al.,
2013; Takeuchi et al., 2013) and thus might be a good
measure of experience-dependent brain changes such as that
provided by lifestyle. However, evidence relating cognitive
reserve measures to functional connectivity remains sparse.
In cognitively normal older adults, it has been suggested
that education may increase the connectivity between frontal
and temporal and parietal regions (Arenaza-Urquijo et al.,
2013a). In AD and MCI patients, education may increase
the connectivity of the posterior cingulate with other areas
of the default mode network (Bozzali et al., 2015). Future
studies with a perspective on functional networks will probably
provide significant advances to the field. Third, the incomplete
understanding of the cascade of events over the course of
AD increases the difficulty to interpret lifestyle effects and
underlying mechanisms. Probably, a further understanding
of the relationships between AD neuroimaging biomarkers
will also help us to better understand lifestyle effects. Brain
regions (such as temporo-parietal metabolism, or hippocampal
volume) that would be affected by AD pathology might be
susceptible to lifestyle effects earlier in life, and may then
play an important role later in the disease by increasing the
threshold of pathology needed to show cognitive impairment.
More generally, future studies including both subjects with
and without pathology (for example, young subjects) will help
understanding lifestyle effects over the life course. In line with
this, models including a life course perspective on the effects of
lifestyle (for example, Richards and Deary, 2005) may provide
a more dynamic perspective to these changes (from childhood
to adulthood). Furthermore, comprehensive studies assessing the
differential or interactive effects of different lifestyle factors will
shed light into the field, since currently the use of different
measures across studies blurs the direct comparison between
studies.
Overall, lifestyle factors may influence the development
and clinical manifestations of AD in several ways. Positive
lifestyle variables may continually exert their effects through
different mechanisms that in turn help maintaining cognitive
performance. Understanding the effects of lifestyle factors across
the disease course will help directing therapeutic interventions.
If protective effects of lifestyle variables mainly occur in pre-
clinical stages, this would imply that lifestyle-based interventions
should be initiated in these earliest stages. Complementarily,
compensatory mechanisms might be promoted later in the
disease which may help decreasing the effects of AD pathology
on cognition.
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